Influence of diet, vitamins and chemotherapeutic agents on gastrointestinal cancer by Kolars, Joseph C & Kurth, Candace L
Journal of Gastroenterology and Hepatology (1998) 13 (Suppl.) SI73-S177 
Influence of diet, vitamins and chemotherapeutic agents on 
gastrointestinal cancer 
JOSEPH C KOLARS* AND CANDACE L KURTHt 
*Shanghai Second Medical University, Shanghai, China and tUniversity of Michigan, Ann Arbor, USA 
Abstract Dietary influences playa major role in the pathogenesis of most gastrointestinal malignan-
cies. However, it has been difficult to define which dietary components will be most significant for any 
given individual. In this article we discuss the methodological challenges to research in this field as 
well as recent observations that have been made on the role of dietary factors in specific digestive tract 
neoplasms. 
Key words: cancer, chemoprevention, cytochrome P450, diet, digestive tract, neoplasms, xenobiotics. 
INTRODUCTION 
Dramatic advances in our understanding of the molec-
ular events associated with the pathogenesis of gas-
trointestinal cancer have taken place over the past 5 
years. The impact of environmental factors on these 
events have been difficult to elucidate, in part due to 
the complex interactions that occur during the trans-
formation from normal to malignant mucosa. It is esti-
mated that one-third of all malignancies are related to 
our diet, with estimates as high as 85% for malignan-
cies of the alimentary canal. I Several important obser-
vations confirm the importance of the environment on 
gastrointestinal cancer, most of which are based on 
changes in cancer incidence when individuals move 
from one area of risk to another. Perhaps the most 
classic of these is based on the observation that resi-
dents ofJapan, where the relative risk of stomach cancer 
is high and colonic cancer low shifts towards that of the 
local population when they move to the West where the 
relative risk of colon cancer is high and stomach cancer 
is low. Similar observations have also been made in 
migrants from China. 2 Although the role of diet is 
unrefutable, the identification of specific dietary factors 
has been harder to define. 
METHODOLOGICAL 
CONSIDERATIONS 
The influence of diet on cancer is of enormous interest 
to the general public with frequent coverage of new 
findings in the lay press. The focus and pertinence of 
these studies are often not adequately discussed. The 
available data regarding the relationship between diet 
and carcinogenesis are at times conflicting due, in part, 
to the following limitations. 
1. Mechanistic studies performed in laboratory 
animals or in ex vivo biological systems contribute valu-
able hypotheses for testing in humans but are often not 
predictive of what may take place in population-based 
studies. 
2. Intraluminal factors (e.g. bile acid concentrations) 
as well as mucosal factors (e.g. P450 enzyme expres-
sion, molecular genotype) differ between individuals 
and compromise our ability to reliably use animal 
models to define the role of specific dietary compo-
nents. 
3. Population studies are time-consuming and expen-
sive. A change in the rate of gastrointestinal cancer 
would likely not be realized for a prolonged interval 
(e.g. 10 years) after the onset of a sustained dietary 
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intervention. Surrogate markers of malignancy (e.g. cel-
lular hyperproliferation) have been of assistance in 
selecting specific dietary interventions that are worthy 
of more prolonged trials. 
4. The complex interplay of dietary components 
makes it difficult to alter one component without affect-
ing the relative presence of other dietary constituents. 
When a specific dietary component is altered, a com-
pensatory change often takes place with other dietary 
constituents. Thus, identification of the component 
with the primary effect can be quite challenging. 
5. Specific micronutrients contained within a food or 
diet are often difficult to identify and highly variable. 
Conclusive scientific evidence that can be used to 
positively influence the health of the community is cur-
rently quite limited. We would like to have evidence 
based on high-quality case-control or cohort epidemi-
ological studies from which we can test hypotheses 
that may help to define the biological events that are 
taking place. However, most studies to date provide 
speculation based on population-based observations 
or, more commonly, carcinogenesis in laboratory 
models. It is imperative that we understand the numer-
ous challenges and potential flaws inherent to these 
approaches. 
DIETARY MACRONUTRIENTS 
Protein, fat and carbohydrates make up the major com-
ponents of our diets and, as such, are often referred to 
as macronutrients. Several randomized controlled 
studies have demonstrated the positive correlation 
between dietary animal fat and carcinoma of the colon.3 
More recently, it would appear that this risk is best asso-
ciated with the ingestion of red meat. When reviewing 
studies on dietary macronutrients, it is important to 
keep in mind that to compare diets that are isocaloric, 
changes in one macronutrient group are invariably asso-
ciated with compensatory changes in one of the other 
groups. For example, it has been advocated in the West 
that dietary fat should be reduced to levels of 30% of 
total calories with hopes of realizing a decrease in car-
diovascular disease and some malignancies (colon, and 
possibly breast or prostate). If such a decrease was 
observed, could we in fact attribute this to a reduction 
in dietary fat or to the increase in carbohydrate that is 
required to maintain the same level of caloric intake? 
This problem was perhaps best illustrated by the early 
observation by Burkitt and colleagues of a reduced inci-
dence of colon cancer in Africa where the diet is high 
in fibre. 4,5 More recent findings would suggest that 
while of probable benefit in reducing the risk for colon 
cancer, a diet high in dietary fibre is usually a marker 
of relatively low animal fat intake which likely has 
greater influence on reducing the risk of colorectal 
cancer than does high fibre intake.6 
DIETARY MICRONUTRIENTS 
The majority of studies regarding diet and cancer focus 
on micronutrients in the diet: pesticides, minerals, vit-
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amins, and other xenobiotics present in relatively small 
quantities that may have either causative or protective 
effects with regard to gastrointestinal malignancy. These 
components are often difficult to measure and are 
highly variable by region, season or crop. Synthetic pes-
ticides have not been demonstrated to playa significant 
role in gastrointestinal malignancies. This is not sur-
prising when one considers that most plants produce 
'natural' pesticides to facilitate survival. These 'natural' 
pesticides are in far greater abundance than synthetic 
pesticides. It is estimated that the average daily Ameri-
can diet contains approximately 0.09 mg of synthetic 
pesticides relative to 1500 mg of 'natural' pesticides 
produced by the plants themselves.7 
The role of vitamins in reducing the risk of gastroin-
testinal malignancy is at best controversial, particularly 
when taken as supplements to a well-balanced diet. 
While diets containing fruits and vegetables are almost 
always associated with lower risks of gastric and col-
orectal cancer, attempts to duplicate these benefits with 
supplements of vitamin A, C, E or beta-carotene have 
generally been unsuccessful. In fact, supplements alone 
may potentially increase the risk of malignancy. In a 
randomized, double-blind, placebo-controlled primary 
prevention trial involving 18 314 smokers and workers 
exposed to asbestos, vitamin A and beta-carotene sup-
plements were associated with an increased risk of death 
from all causes including lung cancer and cardiovascu-
lar disease.8 The chemical complexity of diets prevents 
the easy assignment of benefit or risk to anyone nutri-
ent. Furthermore, careful distinctions must be made 
between reducing dietary deficiencies that may be 
linked to a gastrointestinal cancer risk (e.g. selenium) 
and realizing a benefit from supplementing a diet that 
is not obviously deficient. 
An often overlooked mechanistic consideration 
involves the role of dietary components on mechanisms 
by which carcinogens are metabolized. Dietary car-
cinogens are, in general, lipophilic and ingested as pro-
carcinogens which must undergo oxidative metabolism, 
usually by cytochrome P450 (CYP) enzymes, creating 
a reactive metabolite which can form strategic DNA or 
protein adducts resulting in carcinogenesis. The CYP 
enzymes are substrate specific and variably expressed in 
organs with a wide variability among individuals.9 This 
variability undoubtedly influences the risk an individual 
has of bioactivating a carcinogen as well as the organ 
which is affected. The potential influence of CYP 
enzyme activity on dietary pro carcinogens is perhaps 
best demonstrated when observing the pharmacokinet-
ics of medications when taken with various diets. For 
example, it has been observed that the ingestion of a 
long list of medications with grapefruit juice will have 
a positive increase on oral bioavailability. Watkins and 
colleagues lO demonstrated that grapefruit juice down-
regulates CYP3A4 enzymes within the mucosa of the 
small intestine resulting in decreased first-pass metab-
olism at the site of drug absorption and increased blood 
levels. Of note, this same enzyme is responsible for 
metabolizing a long list of drugs and xenobiotics includ-
ing one of the best-recognized dietary carcinogens, 
aflatoxin B. It is interesting to speculate that dietary 
induced changes in CYP3A4 may, in fact, alter one's 
Diet and gastrointestinal cancer 
risk for aflatoxin B-related hepatocellular carcinoma. 11 
Undoubtedly, other dietary factors place a significant 
role in altering phase 1 oxidation enzymes, which sub-
sequently influence the molecular chain of events 
resulting in carcinogenesis. It is worth noting that 
studies such as these require adherence to a carefully 
controlled diet with close documentation of the CYP 
expression pre- and post-dietary intervention. 
HEPATOCELLULAR CARCINOMA 
Studies by Ozturk and others have clearly demonstrated 
the role of aflatoxin B as a cofactor for hepatocellular 
carcinoma in patients with underlying hepatic 
inflammation such as that which occurs with chronic 
hepatitis.12 Metabolism of dietary aflatoxin B by CYP 
enzymes results in production of a reactive aflatoxin B 
metabolite which can form specific adducts in strategic 
hot-spots, such as codon 249 in the p53 tumour sup-
pression gene. Of note, CYP3A, the most important 
enzyme responsible for this bioactivation, is the pre-
dominant CYP enzyme in human hepatocytes and 
enterocytes.9 
The field of hepatic malignancy chemoprevention is 
populated with anecdotal evidence of beneficial con-
coctions with a paucity of meaningful trials that support 
their efficacy. One intriguing possibility that has been 
explored in a randomized controlled study demon-
strates that polyprenoic acid, a synthetic retinoid, 
significantly reduced the occurrence of second primary 
hepatomas. 13 In the future, we will also have the results 
of an ongoing phase II trial in Qidong, China, on the 
potential beneficial effect of olitipraz, a synthetic dithi-
olthione similar to those found in cruciferous vege-
tables, on preventing hepatocellular malignancy (B 
Levin pers. comm., 1997). 
COLORECTAL MALIGNANCIES 
Colorectal cancer is the number two malignancy in the 
West and rapidly increasing in the East. In Shanghai, 
the incidence of colon cancer has risen by 75% between 
1972 and 1989. 14 Table 1 summarizes the relative role 
of known dietary interventions for colorectal carcinoma 
with those in the definite category supported by multi-
ple, carefully performed, population-based studies. The 
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interventions noted in the definite category have been 
demonstrated to alter the risk by two- to three-fold 
when comparing low and high use groups. However, it 
is not clear that these benefits are additive if each 
beneficial intervention was pursued together with the 
others. 
Over 30 studies have looked at the relation-
ships of fruits and vegetables in protecting against 
colorectal malignancies. However, we have yet to under-
stand the specific agents or their role in influencing car-
cinogenesis. 
A number of observational studies have confirmed a 
beneficial role for non-steroidal anti-inflammatory 
drugs such as aspirin in reducing the risk of mortality 
from colon cancer by 40-50% at doses as low as 
325 mg every other day. 15 These studies have also been 
supported by a number of trials showing regression of 
adenomatous polyps on sulindac. The mechanism of 
this apparent chemopreventive effect is unknown but 
likely involves inhibition of cyclo-oxygenase 1 and 2 as 
well as altered cytokine expression. I 5-17 
Fibre has received a great deal of attention, particu-
larly in the early observations of Burkitt who observed 
an association between high faecal bulk and low cancer 
rates in Africa. As noted earlier, some of the initial 
enthusiasm for fibre was probably due to the reduced 
levels of animal fat in diets containing high fibre. 
However, a meta-analysis of 60 studies suggests that a 
high-fibre diet is protective against colon cancer. IS 
Animal studies suggest that the less fermentable and 
more insoluble fibres (e.g. cellulose, lignins) are likely 
to be the most protective with wheat bran having the 
most consistently positive effect. Potential mechanisms 
of action include lowered pH, increased short-chain 
fatty acids, decreased transit time, adsorption of bile 
acids, and dilution of colonic contents. 5 
Energy balance has been demonstrated to be an 
important risk factor for colorectal malignancy. This is 
likely to be of substantial importance in the West where 
it is estimated that 25% of individuals are overweight. 
The relative contribution of physical activity, body mass 
index (BMI), and caloric intake has been recently 
defined by Slattery et al. who compared a cohort with 
colorectal cancer with a carefully matched control 
group to study the relationship of these variables. 19 Indi-
viduals with high physical activity, low caloric intake, 
and low BMI were defined with a relative risk of 1.0 
and compared with individuals with low physical activ-
ity, high caloric intake, and high BM! who had a rela-
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tive risk of 3.4. When stratifying each of these variables, 
physical activity was the most important determinant of 
risk and greatly modified the increased risk associated 
with high caloric intake or BM!. Thus, physical activity 
seems to be the most important component of 'energy 
balance' in colorectal carcinogenesis. 
UPPER GASTROINTESTINAL 
TRACT MALIGNANCIES 
A list of dietary factors associated with carcinoma of the 
stomach are shown in Table 2. As with colorectal malig-
nancies, ingestion of fruits and vegetables is consistently 
associated with a reduction in the risk of stomach 
cancer. Allium vegetables (e.g. onions, garlic, leeks) 
have been shown in several case-controlled studies to 
reduce the risk of stomach cancer, probably due to their 
organosulphur and flavonol compounds with odds 
ratios between 0.3 and 0.9.20 In a large cohort study 
involving 120852 adults in The Netherlands, ingestion 
of onions (~0.5 onions/day) was associated with a 
reduced risk of carcinoma in the non-cardia region of 
the stomach (RR=0.50, 95% CI=0.26-0.95) during 
3.3 years of follow up. Consumption of leeks or garlic 
was not associated with a reduction in risk. 20 
Oesophageal carcinoma is associated with smoking 
and alcohol in the West but relative dietary deficiencies 
likely account for the higher incidence of adenocarci-
noma of the proximal gastrointestinal tract that is 
observed in the East. A recent phase III study involving 
almost 30 000 adults was completed in the LinXian 
Province of China, an area with a high incidence of ade-
nocarcinoma of the lower oesophagus and proximal 
stomach. A significant reduction of malignancy in 
patients supplemented with beta-carotene, vitamin E 
and selenium (RR=0.91, 95% CI=0.84-0.99) was 
observed, particularly stomach cancer.21 Two other 
trials in China involving patients with dysplasia of the 
proximal gastrointestinal tract failed to demonstrate a 
significant reduction in subsequent cancer or mortality 
when supplemented with a variety of vitamins and min-
erals.22,23 A preliminary study in China also suggests 
that tea may offer some protection against precancer-
ous gastric lesions.24 
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CONCLUSION 
A growing number of high-quality population-based 
studies are providing us with a better understanding of 
the dietary interventions which can reduce our risk of 
gastrointestinal malignancies. The development of reli-
able surrogate biomarkers for these cancers and 
methods to correlate gentotypic factors present in a 
study population will greatly enhance our ability to 
determine which dietary components to pursue or 
avoid. Based on the latter, it is quite likely that these 
will vary depending on the individual. Meanwhile, we 
must be careful to avoid overstating what we know or 
believe to the population that demands of us a check-
list of good and bad dietary ingredients. 
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